APVO News and Press, Aptevo Therapeutics Inc. From 11/09/20

Aptevo Therapeutics (APVO) rose 113% premarket, currently trading at $50.52 after Tang Capital Partners reported a 54.4% stake in new 13D regulatory filing.The reporting persons have expended an aggregate of ~$28.1M to purchase 1.76M Aptevo shares through the open market.APVO share price...

SEATTLE, WA / ACCESSWIRE / November 8, 2020 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that its Board of Directo...

Are These Biotech Penny Stocks On Your Watch List Right Now? Whether you’re trading penny stocks or blue chips , the goal is the same: make money and repeat. However, with a potentially new President coming into office, there could be a few things to monitor right now. Fi...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks faded late to finish mostly flat on Friday, as investors awaited final election vote tallies in four key states, and stimulus negotiat...

Gainers: Oncternal Therapeutics (ONCT) +131%, Aptevo Therapeutics (APVO) +42%, Aurora Cannabis (ACB) +36%, Tilray (TLRY) +29%, Akerna (KERN) +26%.Losers: Clovis Oncology (CLVS) -21%, bluebird bio (BLUE) -17%, Lannett Compan...

Gainers: Altus Midstream (ALTM) +150%.Hall of Fame Resort & Entertainment (HOFV) +118%.Oncternal Therapeutics (ONCT) +82%.Upwork (UPWK) +41%.Aptevo Therapeutics (APVO) +40%.Resideo Technologies (REZI) +35%.Aurora Cannabis (ACB) +34%.Kaixin Auto (KXIN) +33%.Falcon Minerals (...

Nano cap Aptevo Therapeutics (APVO) retraces 12% premarket on increased volume on the heels of its 170% two-day rally after announcing a complete remission ((CR)) in a Phase 1 clinical trial evaluating lead candidate APVO436 in patients with acute myeloid leukemia ((AML)) ...

bluebird bio (BLUE) -15% on Q3 earnings release.Hanesbrands (HBI) -14% on Q3 earnings release.Ping Identity Holding (PING) -13% on Q3 earnings release.Aptevo Therapeutics (APVO) -12% after providing updates on preliminary data in its ongoing APVO436 Phase 1 ...

Gainers: Biogen (BIIB) +43%, Digirad (DRAD) +28%, Supernus Pharmaceuticals (SUPN) +21%, Jupiter Wellness (JUPW) +3%, Cassava Sciences (SAVA) +13%.Losers: Repro Med Systems (KRMD) -28%, Aptevo Therapeutics (APVO) -13%, Allogene Therapeutics (AL...

RealNetworks (RNWK) -12% on Q3 earnings release.Aptevo Therapeutics (APVO) -12%.vTv Therapeutics (VTVT) -8% on reporting baseline characteristics for the enrolled subjects in the ongoing Elevage clinical study of azeliragon as a potential treatment for mild Alzhe...